Understanding how fungal pathogens build their cell walls and respond to antifungal treatments
Revealing the Cell Wall Organization of Fungal Pathogens and Structural Responses to Antifungal Drugs Using Cellular Solid-State NMR
This study is looking at how certain fungi, like Aspergillus and Candida, build their protective walls to see why they can resist antifungal medicines, with the hope of finding new ways to treat infections for people who are seriously ill.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan State University NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project ID | NIH-11000809 on NIH RePORTER |
What this research studies
This research investigates the cell wall structures of common fungal pathogens, such as Aspergillus fumigatus and Candida albicans, to better understand how these fungi resist antifungal drugs. By using advanced solid-state nuclear magnetic resonance (ssNMR) technology, the researchers aim to uncover the molecular details of the cell wall organization and its changes in response to antifungal agents. This knowledge could lead to the development of new treatments that specifically target the fungal cell wall, potentially improving outcomes for patients with invasive fungal infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are immunocompromised patients who are at high risk for invasive fungal infections.
Not a fit: Patients with fungal infections that are not caused by the specific pathogens being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective antifungal therapies with reduced toxicity for patients suffering from serious fungal infections.
How similar studies have performed: Other research has shown promise in targeting fungal cell walls, but this approach is still relatively novel and untested in the context of the specific pathogens being studied.
Where this research is happening
East Lansing, United States
- Michigan State University — East Lansing, United States (Active)
Researchers
- Principal investigator: Wang, Tuo — Michigan State University
- Study coordinator: Wang, Tuo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.